Tune in Medical Tourism: The Mario Solis Marich Show
July 18th, 2008 by -- the moderator
That the phenomenon of medical tourism and travel poses political challenges in the United States is clear, with healthcare costs and quality among the top issues in the ‘08 presidential campaign. What may surprise some people is that, for the most part, medical tourism is not necessarily a controversial political issue.
People from all areas of the ideological spectrum recognize that medical tourism can cut costs for healthcare consumers. There is plenty of disagreement on how to fix the American healthcare system. There is very little about the fact that consumers need relief on the cost of healthcare, and that medical tourism helps with that.
Stephanie Sulger of BridgeHealth International was on the Mario Solis Marich Show the other day — a progressive talk radio program. It’s healthy that medical tourism is being addressed for what it is, in depth, in a bipartisan way. In Beauty from Afar, among my last-chapter predictions was that medical tourism would find its way into the national dialog during the 2008 presidential campaign. Without patting myself on the back too much, I’m feeling kind of “right” about that.
Here’s the first two parts of the interview. Mario is bringing Stephanie back on the show on Sunday to continue the discussion and we’ll update with more audio on Monday.
Part 1:
Part 2:
Category: Inside BridgeHealth International, Medical Travel in the News, Perspectives on Medical Travel | No Comments »
Sulger, a pioneer in the medical travel and tourism industry, is frequently called upon to assess health and safety factors at medical destinations and is often quoted in media such as The New York Times and Good Housekeeping magazine, as well as appearing on ABC television speaking about issues facing the medical travel industry. In her career, she has assisted more than 3,000 clients in obtaining care in overseas facilities, including for orthopedics, neurosurgery, general surgery, cosmetic surgery, GYN, urology and stem cell therapy.





